Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Project Inform perspective

Showing results (121-130 of 280) with videos related to

Pageof 28
Sort By:
Project Inform Perspective|August 25, 2010
Hepatitis C information
Project Inform Perspective|August 25, 2010
Protecting people with HIV in the California budget
Project Inform Perspective|March 3, 2009
Project Inform considers its role in a national strategy to eliminate the epidemicDana Van Gorder
Project Inform Perspective|March 3, 2009
Nano comes to HIVMartin Delaney
Project Inform Perspective|March 4, 2009
The cure: why, whether, how and when?Martin Delaney
Project Inform Perspective|June 5, 2009
Truvada and Epivir are similar at suppressing HIV
Project Inform Perspective|June 5, 2009
Two newcomers may challenge ritonavir's position as the only booster for HIV therapy
Project Inform Perspective|June 5, 2009
Isentress equal to Sustiva in first line therapy
Project Inform Perspective|July 1, 1997
Study of GM-CSF enrolling
Project Inform Perspective|July 1, 1997
1592 update
Pageof 28

Showing results (121-130 of 280) with videos related to

Sort By:
Pageof 28
Project Inform Perspective|August 25, 2010
Hepatitis C information
Project Inform Perspective|August 25, 2010
Protecting people with HIV in the California budget
Project Inform Perspective|March 3, 2009
Project Inform considers its role in a national strategy to eliminate the epidemicDana Van Gorder
Project Inform Perspective|March 3, 2009
Nano comes to HIVMartin Delaney
Project Inform Perspective|March 4, 2009
The cure: why, whether, how and when?Martin Delaney
Project Inform Perspective|June 5, 2009
Truvada and Epivir are similar at suppressing HIV
Project Inform Perspective|June 5, 2009
Two newcomers may challenge ritonavir's position as the only booster for HIV therapy
Project Inform Perspective|June 5, 2009
Isentress equal to Sustiva in first line therapy
Project Inform Perspective|July 1, 1997
Study of GM-CSF enrolling
Project Inform Perspective|July 1, 1997
1592 update
Pageof 28